KalVista Pharmaceuticals ... (KALV)
undefined
undefined%
At close: undefined
8.69
0.06%
After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13
Revenue - - - 12.69M 12.69M 16.13M 8.39M 1.50M 2.13M 1.80M 415.00K 1.54M
Cost of Revenue 86.17M 802.00K 743.00K 651.00K 40.19K 35.02K 18.24K 12.67K 14.66K 8.29K - -
Gross Profit -86.17M -802.00K -743.00K 12.04M 12.65M 16.09M 8.38M 1.49M 2.12M 1.80M 415.00K 1.54M
Operating Income -140.44M -110.87M -96.61M -57.92M -40.53M -29.82M -18.70M -22.34M -15.18M -8.09M -5.22M -1.83M
Interest Income - 2.23M 1.09M 903.00K 1.83M 1.40M 82.00K 36.00K 50.00K 19.00K 2.00K 1K
Pretax Income -135.10M -92.91M -82.34M -46.24M -29.24M -20.69M -15.80M -18.60M -11.44M -7.23M -5.68M -2.05M
Net Income -126.64M -74.85M -68.51M -44.49M -29.12M -20.82M -15.80M -18.60M -11.44M -7.23M -5.68M -2.05M
Selling & General & Admin 54.28M 30.59M 26.45M 16.64M 13.03M 10.93M 8.86M 11.18M 2.65M 1.61M 1.40M 1.41M
Research & Development 86.17M 80.28M 70.17M 41.29M 40.19M 35.02M 18.24M 12.67M 14.66M 8.29M 4.23M 1.96M
Other Expenses -86.17M 15.64M 14.72M 9.93M 9.83M 7.68M 4.39M 2.33M 2.03M 844.00K -59.00K 35.00K
Operating Expenses 54.28M 110.87M 96.61M 57.92M 53.22M 45.95M 27.10M 23.84M 17.31M 9.89M 5.63M 3.37M
Interest Expense - - 1.09M - - - - - - - 405.00K 256.00K
Selling & Marketing Expenses - - - - - - - - - - - -
Cost & Expenses 140.44M 110.87M 96.61M 57.92M 53.22M 45.95M 27.10M 23.84M 17.31M 9.89M 5.63M 3.37M
Income Tax -8.45M -18.05M -13.83M -1.75M -124.00K 124.00K -1.33M -5.11M -5.41M -863.00K 462.00K 220.00K
Shares Outstanding (Basic) 36.79M 27.89M 24.47M 19.09M 17.75M 15.08M 10.32M 9.71M 4.77M 1.17M 724.80K 724.80K
Shares Outstanding (Diluted) 36.79M 27.89M 24.47M 19.09M 17.75M 15.08M 10.32M 9.71M 4.77M 1.17M 724.80K 724.80K
EPS (Basic) -3.44 -2.68 -2.8 -2.33 -1.64 -1.38 -1.53 -1.92 -2.4 -6.17 -7.83 -2.83
EPS (Diluted) -3.44 -2.68 -2.8 -2.33 -1.64 -1.38 -1.53 -1.92 -2.4 -6.17 -7.83 -2.83
EBITDA -134.28M -92.11M -81.60M -45.59M -40.02M -29.44M -18.52M -22.30M -15.15M -8.05M -5.25M -1.76M
Depreciation & Amortization 816.00K 802.00K 743.00K 651.00K 525.00K 378.00K 180.00K 40.00K 133.00K 38.00K 27.00K 38.00K